Alliance Pharma Plc

Alliance Pharma (APH)

Company name:Alliance Pharma Plc
EPIC:APHTrading Currency:GBX
Market Sector:AS50ISIN:GB0031030819
Market Segment:AMSMShare Type:DE
WWW Address:Description:ORD 1P
 Price Price Change [%] Bid Offer Open High Low Volume
 85.00 -0.4 [-0.47] 84.50 85.00 86.00 86.00 84.50 937,088
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 452.71 532.61 0.01 5.09 0.54 16.70 0.64 90.90 - 57.10

Alliance Pharma Key Figures

(at previous day's close)
Market Cap.452.71m
Shares In Issue532.61m
Prev. Close85.40
PE Ratio16.70 
Dividend Yield0.64%
EPS - basic5.09p
Dividend PS0.54p
Dividend Cover9.43 
Cash Flow PS6.71p
Return On Equity (ROE)9.66%
Operating Margin24.25%
PEG Factor0.44 
EPS Growth Rate37.94%
Dividends PS Growth Rate-63.27%
Net Debt115.63m
Gross Gearing32.74%
Quick Assets50.53m
Net Working Capital41.84m
Intangibles / Fixed Assets96.22%
Turnover PS25.47p
Pre-Tax Profit PS6.18p
Retained Profit PS3.55p
Cash PS3.35p
Net Cash PS-1.20p
Net Tangible Asset Value PS *-10.23p
Net Asset Value PS51.48p
Spread0.50 (0.59%) 

Alliance Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week87.6083.50
4 weeks89.0083.50
12 weeks90.9072.20
1 year90.9057.10

Share Price Chart (5 years)

Alliance Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week86.00-1.00-1.1683.501.2784.90
4 weeks87.60-2.60-2.9783.500.8485.50
12 weeks73.3011.7015.9672.201.3281.82
26 weeks72.0013.0018.0670.501.1978.20
1 year76.009.0011.8457.101.0275.55
3 years67.4017.6026.1157.101.1777.71
5 years47.7537.2578.0140.501.0069.72

Alliance Pharma Key Management Ratios

Alliance Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio56.00 
PE Ratio16.70 
Tobin's Q Ratio 1.12 
Tobin's Q Ratio (excl. intangibles)6.15 
Dividend Yield0.64%
Market-to-Book Ratio1.65 
Price-to-Pre-Tax Profit PS13.76 
Price-to-Retained Profit PS23.97 
Price-to-Cash Flow PS12.66 
Price-to-Sales PS3.34 
Price-to-Net Tangible Asset Value PS-8.31 
Price-to-Cash PS25.39 
Net Working Capital PS7.86 
Price Pct to Working Capital PS10.82%
Earnings Yield5.99%
Average PE13.49 
Years in average5 
PE to PE average123.77%

Alliance Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio28.49%
Debt-to-Equity Ratio0.40 
Debt-to-Equity Ratio (excl. Intgbl)-2.01 
Debt-to-Equity Market Value0.24 
Net Gearing28.37%
Net Gearing (excl. Intangibles)146.41%
Gross Gearing32.74%
Gross Gearing (excl. Intangibles)168.98%
Gearing Under 1 Year5.94%
Gearing Under 1 Year (excl. Intgbl)30.65%
(Liquidity Ratios)
Net Working Capital to Total Assets10.27%
Current Ratio2.73 
Quick Ratio (Acid Test)2.09 
Liquidity Ratio0.74 
Cash & Equiv/Current Assets26.99%
(Solvency Ratios)
Enterprise Value544.14m
CFO/Attributable Profit1.35 
Total Debt/Equity Market Value0.29 
Total Debt/Sales0.98 
Total Debt/Pre-Tax Profit4.06 
Total Debt133.46m
Total Debt/Net Current Assets3.19%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth1.82%
10 yr Compound Earnings Growth2.54%
Earn drops > 5% in 10yrs7 
Beta (60-Mnth)Beta (36-Mnth)

Alliance Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)8.58%
Return On Assets (ROA)6.53%
Net Profit Margin19.52%
Assets Turnover0.33 
Return On Equity (ROE)9.66%
Return On Investment (ROI)7.62%
Dividend Payout Ratio10.61%
Plowback Ratio89.39%
Growth from Plowback Ratio8.99%
Net Income Of Revenues13.92%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.52 
Fixed Assets Turnover0.40 
Current Assets Turnover2.14 
Net Working Capital Turnover 
Inventory Turnover7.93 
(Other Operating Ratios)
Total Assets-to-Sales2.99 
Debt Collection Period85.70Days

Alliance Pharma Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
22 Sep 2020InterimGBX0.5331/12/201931/12/202017/12/202018/12/202007/01/2021-
24 Sep 2019InterimGBX0.5431/12/201831/12/201919/12/201920/12/201910/01/20200.54
26 Mar 2019FinalGBX0.9831/12/201731/12/201813/06/201914/06/201911/07/20191.47
19 Sep 2018InterimGBX0.4931/12/201731/12/201820/12/201821/12/201810/01/2019-
27 Mar 2018FinalGBX0.8931/12/201631/12/201714/06/201815/06/201811/07/20181.33
13 Sep 2017InterimGBX0.4431/12/201631/12/201721/12/201722/12/201711/01/2018-
29 Mar 2017FinalGBX0.8131/12/201531/12/201615/06/201716/06/201712/07/20171.21
14 Sep 2016InterimGBX0.4031/12/201531/12/201622/12/201623/12/201612/01/2017-
07 Apr 2016FinalGBX0.7431/12/201431/12/201516/06/201617/06/201613/07/20161.10
09 Sep 2015InterimGBX0.3631/12/201431/12/201524/12/201529/12/201514/01/2016-
25 Mar 2015FinalGBX0.6731/12/201331/12/201418/06/201519/06/201515/07/20151.00
10 Sep 2014InterimGBX0.3331/12/201331/12/201403/12/201405/12/201415/01/2015-
26 Mar 2014FinalGBX0.6131/12/201231/12/201311/06/201413/06/201410/07/20140.91
11 Sep 2013InterimGBX0.3031/12/201231/12/201304/12/201306/12/201315/01/2014-
21 Mar 2013FinalGBX0.5531/12/201131/12/201212/06/201314/06/201311/07/20130.83
12 Sep 2012InterimGBX0.2831/12/201131/12/201205/12/201207/12/201215/01/2013-
22 Mar 2012FinalGBX0.5031/12/201031/12/201113/06/201215/06/201212/07/20120.75
07 Sep 2011InterimGBX0.2531/12/201031/12/201130/11/201102/12/201113/01/2012-
23 Mar 2011FinalGBX0.4031/12/200931/12/201015/06/201117/06/201114/07/20110.57
08 Sep 2010InterimGBX0.1731/12/200931/12/201001/12/201003/12/201014/01/2011-
24 Mar 2010FinalGBX0.2331/12/200831/12/200916/06/201018/06/201015/07/20100.30
09 Sep 2009InterimGBX0.0730/12/200830/06/200902/12/200904/12/200915/01/2010-

Alliance Pharma Fundamentals

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
pre tax profit22.2222.79%28.3727.46%22.8019.29%32.8924.25%m
attributable profit18.0918.56%28.9127.98%18.3615.53%26.4819.52%m
retained profit12.9413.27%23.1822.44%12.0110.16%18.8813.92%m
eps - basic (p)3.85 6.10 3.69 5.09 
eps - diluted (p)3.82 6.03 3.60 4.99 
dividends per share1.21 1.33 1.47 0.54 

Alliance Pharma Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
fixed assets fixed assets1.810.56%3.381.00%7.591.88%11.552.83%m
intangibles intangibles264.8382.57%278.6282.81%335.2483.06%328.6680.63%m
fixed investments fixed investments1.640.51%1.710.51%0.180.04%1.370.34%m
current assets - other current assets - other--%--%--%--%m
stocks stocks15.364.79%14.254.23%18.714.63%15.523.81%m
debtors debtors29.889.32%27.338.12%30.997.68%32.708.02%m
cash & securities cash & securities7.222.25%11.183.32%10.892.70%17.834.37%m
creditors - short creditors - short50.2815.68%60.8118.07%91.7222.73%24.215.94%m
creditors - long creditors - long91.2028.43%72.2921.48%59.6914.79%109.2526.80%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves179.2655.89%203.3860.44%252.2062.49%274.1867.26%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Alliance Pharma Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF16.9326.5822.1735.76m
Pre-Financing CF8.9010.67-36.9132.47m
Retained CF3.434.22-0.337.28m

Alliance Pharma Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Numis Securities LimitedMarket Maker(MMF)Broker/DealerNUMSRAZHGB2LBIC
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Alliance P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210302 20:13:39